Support members through the transition, at population scale.
MARKABLE helps members notice and self-monitor perimenopause-related wellness patterns from their own phone, and prepare for conversations with their own clinician. It reaches members far from a clinic, with no lab visit and no referral or pre-authorisation. The health-equity story an insurer or employer can stand behind.
One of the largest underserved groups in women's health.
Most women pass through the perimenopause transition, and most experience vasomotor symptoms during it. Against that backdrop, MARKABLE offers insurers, employers and health systems a private, non-invasive way to reach these women where they already are, on the phone in their hand.
symptoms1
pre-authorisation
stop within the first year2
member, at home
MARKABLE gives members a simple way to stay aware of their own wellness patterns and arrive at their own clinician conversations prepared.
MARKABLE is a general wellness product, not a medical device, and does not replace diagnosis or medical care.
Member engagement, at population scale.
MARKABLE runs on the phone members already carry, so a plan can offer it across the whole population, including members who live far from a clinic.
Members start from their own phone.
A selfie and a seven-minute check, at home, on any smartphone. There is no lab visit and no referral or pre-authorisation to complete first.
Five wellness signals, one picture.
Facial biomarkers, cognition, hearing, vision and symptoms are read together into one structured, longitudinal wellness summary the member can follow over time.
She arrives prepared for her own clinician.
The member brings a clear, structured wellness picture to the conversation she chooses to have, so the visit starts informed rather than from a blank page.
Reach that scales across the population.
Because it runs on a device members already own, a plan can offer MARKABLE to everyone, with no hardware to ship and no clinic appointment to book.
A smartphone reaches members a clinic rarely does.
Monitoring a hormonal transition through the traditional path can mean a clinic appointment, a blood draw, a referral or pre-authorisation, transportation and time away from work. MARKABLE asks for a smartphone and about seven minutes, at home, on the member's own schedule.
Five wellness signals, one member profile.
MARKABLE reads five wellness signals and fuses them into a single longitudinal wellness profile per member. Here is what each signal reads, and why it belongs in the picture.
Facial biomarkers
A single selfie reads a rich set of markers across the eye region, facial structure and volume, cutaneous texture, tone and the hairline, the morphological signals associated with the hormonal transition.
Cognition
Short on-phone games read processing speed, word retrieval, working memory and recall, the cognitive domains associated with hormonal change.
Hearing
Sound tasks read auditory processing, one of the sensory systems associated with the transition.
Vision
Contrast and color tasks read visual processing, a second independent sensory signal.
Symptoms
70+ symptom domains, captured structured, surface the patterns a woman rarely reports on her own.
Built on real data, from real women.
In our pilot, the fused model reached an AUC of 0.87. It is early and observational, and we say so plainly. The current model fuses facial, symptom and cognitive signals across more than seventy symptom domains, and the research grows with every check. A paper is in preparation for peer review, and full validation detail is available on request.
observational pilot
signals fused
domains mapped
her own phone
Questions from health plan leaders
Is MARKABLE a medical device? +
Does MARKABLE reduce medical costs or claims? +
How do you measure success? +
Who owns the member data? +
How is MARKABLE priced for a plan? +
How does this fit our systems? +
Can we run a pilot? +
What clinical evidence exists? +
Bring perimenopause wellness to your members.
Book a short consultation and we will walk you through how MARKABLE engages members and supports them through the transition, at population scale.